These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 9453614

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection.
    Fry SR, Chen AY, Daggard G, Mukkur TKS.
    J Med Microbiol; 2008 Jan; 57(Pt 1):28-35. PubMed ID: 18065664
    [Abstract] [Full Text] [Related]

  • 24. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
    Dunne A, Mielke LA, Allen AC, Sutton CE, Higgs R, Cunningham CC, Higgins SC, Mills KH.
    Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
    David S, van Furth R, Mooi FR.
    Vaccine; 2004 May 07; 22(15-16):1892-8. PubMed ID: 15121300
    [Abstract] [Full Text] [Related]

  • 30. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ, McNeela E, Murphy GA, Stewart H, O'hagan D, Pizza M, Rappuoli R, Mills KH.
    Infect Immun; 1999 Dec 07; 67(12):6270-80. PubMed ID: 10569737
    [Abstract] [Full Text] [Related]

  • 31. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
    Bottero D, Gaillard ME, Errea A, Moreno G, Zurita E, Pianciola L, Rumbo M, Hozbor D.
    Vaccine; 2013 Oct 25; 31(45):5262-8. PubMed ID: 24012570
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
    Suzuki K, Shinzawa N, Ishigaki K, Nakamura K, Abe H, Fukui-Miyazaki A, Ikuta K, Horiguchi Y.
    Microbiol Immunol; 2017 Sep 25; 61(9):371-379. PubMed ID: 28752940
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.